Q3 2024 13F Holders as of 9/30/2024
-
Type / Class
-
Equity / Ordinary shares, par value NIS 0.10 per share
-
Shares outstanding
-
2.05B
-
Number of holders
-
31
-
Total 13F shares, excl. options
-
2.49M
-
Shares change
-
-940K
-
Total reported value, excl. options
-
$1.33M
-
Value change
-
-$508K
-
Put/Call ratio
-
0.14
-
Number of buys
-
13
-
Number of sells
-
-11
-
Price
-
$0.54
Significant Holders of BioLineRx Ltd. - Ordinary shares, par value NIS 0.10 per share (BLRX) as of Q3 2024
35 filings reported holding BLRX - BioLineRx Ltd. - Ordinary shares, par value NIS 0.10 per share as of Q3 2024.
BioLineRx Ltd. - Ordinary shares, par value NIS 0.10 per share (BLRX) has 31 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 2.49M shares
of 2.05B outstanding shares and own 0.12% of the company stock.
Largest 10 shareholders include Alyeska Investment Group, L.P. (866K shares), ENVESTNET ASSET MANAGEMENT INC (239K shares), MORGAN STANLEY (198K shares), Values First Advisors, Inc. (198K shares), PVG ASSET MANAGEMENT CORP (157K shares), Atria Investments, Inc (134K shares), Atria Wealth Solutions, Inc. (94.1K shares), LPL Financial LLC (92K shares), Cetera Investment Advisers (80.2K shares), and XTX Topco Ltd (44.1K shares).
This table shows the top 31 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.